Professional Publications
Publications (3663)
Schwarz, J.; Pytlík, R.; Doubek, M.; Brychtová, Y.; Dulíček, P.; Campr, V.; Křen, L.; Penka, M.
Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia
[year of publication 2007, impact factor 2.733]
Baláš, J.; Giles, D.; Chrastinová, L.; Kárníková, K.; Kodejška, J.; Hlaváčková, A.; Vomáčko, L.; Draper, N.
The effect of potential fall distance on hormonal response in rock climbing
[year of publication 2016, impact factor 2.733 ]
Šestáková, Š.; Šálek, C.; Remešová, H.
DNA methylation validation methods: a coherent review with practical comparison
[year of publication 2019, impact factor 2.711 ]
Houska, M.; Brynda, E.; Solovyev, A.; Brouckova, A.; Krizova, P.; Vanickova, M.; Dyr, J.E.
Hemocompatible albumin-heparin coatings prepared by the layer-by-layer technique : the effect of layer ordering on thrombin inhibition and platelet adhesion
[year of publication 2008, impact factor 2.706]
Šárová, I.; Březinová, J.; Zemanová, Z.; Gančarčíková, M.; Vydra, J.; Čermák, J.; Michalová, K.
Rearrangement of 11q13.2 region in two patients with acute myeloid leukemia
[year of publication 2013, impact factor 2.692 ]
Cermak, J.; Jonasova, A.; Vondrakova, J.; Cervinek, L.; Belohlavkova, P.; Neuwirtova, R.
A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes
[year of publication 2013, impact factor 2.692 ]
Zemanova, Z.; Michalova, K.; Buryova, H.; Brezinova, J.; Kostylkova, K.; Bystricka, D.; Novakova, M.; Sarova, I.; Izakova, S.; Lizcova, L.; Ransdorfova, S.; Krejcik, Z.; Dostalova Merkerova, M.; Dohnalova, A.; Siskova, M.; Jonasova, A.; Neuwirtova, R.; Cermak, J.
Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis
[year of publication 2014, impact factor 2.692 ]
DNMT3A mutations in AML: a new prognostic factor?
[year of publication 2013, impact factor 2.692 ]
Uherková, L.; Vančurová, I.; Vyhlídalová, I.; Pleschnerová, M.; Špička, I.; Mihalová, R.; Březinová, J.; Hodný, Z.; Čermáková, K.; Polanská, V.; Marinov, I.; Jedelský, P.L.; Kuželová, K.; Stöckbauer, P.
Novel human multiple myeloma cell line UHKT-893
[year of publication 2013, impact factor 2.692 ]
Ludvikova, V.; Hamsikova, E.; Sobotkova, E.; Lucansky, V.; Smahel, M.; Vonka, V.:
Use of polyclonal rabbit antibodies for detection of the bcr-abl fusion zone in cells transfected with experimental bcr-abl DNA vaccines.
[year of publication 2006, impact factor 2.681]
Mikyskova, R.; Bubenik, J.; Vonka, V.; Smahel, M.; Indrova, M.; Bieblova, J.; Simova, J.; Jandlova, T.:
Immune escape phenotype of HPV16-associated tumours : MHC class I expression changes during progression and therapy.
[year of publication 2006, impact factor 2.681]
Smahel, M.; Smahelova, J.; Tejklova, P.; Tachezy, R.; Marinov, I.:
Characterization of cell lines derived from tumors induced by TC-1 cells in mice preimmunized against HPV16 E7 oncoprotein.
[year of publication 2006, impact factor 2.681]
Chemotherapy‐induced survivin regulation in acute myeloid leukemia cells
[year of publication 2021, impact factor 2.679 ]
Cmejlova, J.; Cerna, Z.; Votava, T.; Pospisilova, D.; Cmejla, R.
Identification of a new in-frame deletion of six amino acids in ribosomal protein S19 in a patient with Diamond-Blackfan anemia
[year of publication 2007, impact factor 2.678]
Grebeňová, D.; Kuželová, K.; Pluskalová, M.; Pešlová, G.; Halada, P.; Hrkal, Z.
The proteomic study of sodium butyrate antiproliferative/cytodifferentiation effects on K562 cells
[year of publication 2006, impact factor 2.678]
Provaznikova, D.; Houskova, K.; Radovska, A.; Salaj, P.; Hrachovinova, I.
Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assays
[year of publication 2015, impact factor 2.673 ]
Pavlík, T.; Janoušová, E.; Pospíšil, Z.; Mužík, J.; Žáčková, D.; Ráčil, Z.; Klamová, H.; Cetkovský, P.; Trněný, M.; Mayer, J.; Dušek, L.
Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy
[year of publication 2011, impact factor 2.668 ]
Zahlavova, L.; Bendukidze, N.; Ivaskova, E.
HLA-A, -B, -Cw, -DPB1, -DQA1, -DQB1 and -DRB1 allele frequencies in a population from the Czech Republic
[year of publication 2006, impact factor 2.664]
Toman, O.; Kabickova, T.; Vit, O.; Fiser, R.; Machova Polakova, K.; Zach, J.; Linhartova, J.; Vyoral, D.; Petrak, J.
Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target
[year of publication 2016, impact factor 2.662 ]
Proteomic analysis of serum for identification of potential biomarkers predicting response of patients with refractory multiple myeloma to bortezomib-based therapy
[year of publication 2017, impact factor 2.658 ]